Vical updates Allovectin-7 melanoma program.
D002140:California; D017322:Clinical Trials, Phase II as Topic; D017326:Clinical Trials, Phase III as Topic / Q000592:standards*; D004247:DNA; D004274:DNA, Recombinant; D006801:Humans; D008055:Lipids / Q000008:administration & dosage / Q000627:therapeutic use*; D008545:Melanoma / Q000188:drug therapy*; D010957:Plasmids / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
C096492:Allovectin-7; D004274:DNA, Recombinant; D008055:Lipids; D004247:DNA